Trade Summary

Yesterday, EVNIN LUKE, serving as Dir at Werewolf Therapeutics, Inc. (HOWL), sold 191,762 shares at $0.45 per share, for a total transaction value of $86,560.29. Following this transaction, EVNIN LUKE now holds 763,685 shares of HOWL.

This sale represents a 20.07% decrease in EVNIN LUKE's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 6:18 PM ET, meaning the disclosure happened on the same day as the trade.

Werewolf Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.